IL142088A0 - Methods and compositions for inhibiting neoplastic cell growth - Google Patents

Methods and compositions for inhibiting neoplastic cell growth

Info

Publication number
IL142088A0
IL142088A0 IL14208899A IL14208899A IL142088A0 IL 142088 A0 IL142088 A0 IL 142088A0 IL 14208899 A IL14208899 A IL 14208899A IL 14208899 A IL14208899 A IL 14208899A IL 142088 A0 IL142088 A0 IL 142088A0
Authority
IL
Israel
Prior art keywords
methods
compositions
cell growth
neoplastic cell
inhibiting neoplastic
Prior art date
Application number
IL14208899A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL142088A0 publication Critical patent/IL142088A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14208899A 1998-10-13 1999-10-05 Methods and compositions for inhibiting neoplastic cell growth IL142088A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10408098P 1998-10-13 1998-10-13
PCT/US1999/023089 WO2000021996A2 (fr) 1998-10-13 1999-10-05 Procedes et compositions inhibant la croissance des cellules neoplasiques

Publications (1)

Publication Number Publication Date
IL142088A0 true IL142088A0 (en) 2002-03-10

Family

ID=22298575

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14208899A IL142088A0 (en) 1998-10-13 1999-10-05 Methods and compositions for inhibiting neoplastic cell growth
IL142088A IL142088A (en) 1998-10-13 2001-03-19 Use of PRO172 polypeptide for the preparation of pharmaceutical preparations for inhibiting the growth of neoplastic cells
IL189502A IL189502A0 (en) 1998-10-13 2008-02-13 Methods and compositions for inhibiting neoplastic cell growth

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL142088A IL142088A (en) 1998-10-13 2001-03-19 Use of PRO172 polypeptide for the preparation of pharmaceutical preparations for inhibiting the growth of neoplastic cells
IL189502A IL189502A0 (en) 1998-10-13 2008-02-13 Methods and compositions for inhibiting neoplastic cell growth

Country Status (15)

Country Link
EP (1) EP1121439B1 (fr)
JP (1) JP2002527452A (fr)
KR (2) KR100448427B1 (fr)
AT (2) ATE332970T1 (fr)
AU (1) AU758462B2 (fr)
CA (1) CA2344465A1 (fr)
DE (2) DE69932342T2 (fr)
DK (2) DK1121439T3 (fr)
ES (2) ES2268901T3 (fr)
IL (3) IL142088A0 (fr)
MX (1) MXPA01003636A (fr)
NZ (1) NZ510584A (fr)
PT (2) PT1121439E (fr)
WO (1) WO2000021996A2 (fr)
ZA (1) ZA200102380B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
CA2406855A1 (fr) * 2000-04-21 2001-11-01 Takeda Chemical Industries, Ltd. Nouveaux polypeptides appartenant a la famille insuline/igf/relaxine et adn correspondants
CA2710775A1 (fr) * 2007-12-28 2009-07-09 Bioinvent International Ab Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
AU9312198A (en) * 1997-09-17 1999-04-05 Genentech Inc. Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
NZ503343A (en) * 1997-09-17 2002-09-27 Genentech Inc Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells

Also Published As

Publication number Publication date
DE69932342D1 (de) 2006-08-24
DK1518930T3 (da) 2007-10-01
IL189502A0 (en) 2008-06-05
ES2268901T3 (es) 2007-03-16
IL142088A (en) 2008-11-26
EP1121439A2 (fr) 2001-08-08
JP2002527452A (ja) 2002-08-27
PT1121439E (pt) 2006-12-29
WO2000021996A2 (fr) 2000-04-20
DE69936234D1 (de) 2007-07-12
KR100448427B1 (ko) 2004-09-16
AU1200500A (en) 2000-05-01
ZA200102380B (en) 2002-03-22
ATE332970T1 (de) 2006-08-15
ATE363536T1 (de) 2007-06-15
PT1518930E (pt) 2007-09-04
AU758462B2 (en) 2003-03-20
CA2344465A1 (fr) 2000-04-20
MXPA01003636A (es) 2003-10-14
KR20010085915A (ko) 2001-09-07
DE69932342T2 (de) 2007-07-12
ES2290606T3 (es) 2008-02-16
WO2000021996A3 (fr) 2000-11-09
KR100448426B1 (ko) 2004-09-13
KR20030096387A (ko) 2003-12-24
NZ510584A (en) 2003-04-29
EP1121439B1 (fr) 2006-07-12
DK1121439T3 (da) 2006-11-13
DE69936234T2 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
BG105270A (en) Tetrahydropyridoethers
AP9901478A0 (en) Compounds for the treatment of ischemia.
WO2002080754A3 (fr) Methodes d'utilisation d'une annexine permettant de visualiser la mort cellulaire in vivo et de traiter des etats pathologiques
BG104392A (en) Methods for the modulation of serin/treonin protein kinase function with compounds based on 5-azaquinoxaline
WO2001075178A3 (fr) Methodes d'identification d'aptameres peptidiques pouvant alterer un phenotype cellulaire
CY2538B1 (en) Tetrahydropyrido compounds
WO2003103581A3 (fr) Compositions et methodes de croissance et de protection du foie
IL137229A0 (en) Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
DE69938192D1 (en) Imidazonaphthyridine
IL141513A0 (en) Inhibitors of bacterial nad synthetase
WO2000021513A3 (fr) Procedes pour traiter la sclerose en plaques
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
MX9605072A (es) Dispositivo dispensador para pretratamiento.
EP0943620A3 (fr) Dérivés de l'acide bétulinique pour inhibition de la croissance des cancers
MXPA05001690A (es) Estrategia de deteccion para farmacos anticancer.
AU2002228913A1 (en) Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer
EP1518930A3 (fr) Procédés et compositions pour l'inhibition de la croissance de cellules néoplastiques
WO2000012754A8 (fr) Procede d'identification de substances pour le traitement de troubles induits par la c-jun
MY117925A (en) Compounds for the inhibition of farnesyl protein transferase.
MXPA02008014A (es) Composiciones inhibidoras de tumores de 1-nitroacridina.
AU5967899A (en) Inhibition of alopecia
MXPA00006072A (es) Metodos y composiciones para inhibir el crecimiento de celulas tumorales.
AU2003282035A1 (en) Modulation of s6 kinase activity for the treatment of obestiy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed